This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03798/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03798/identifier/kegg-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03798/identifier/pubchem-compound/
n13http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB03798/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03798/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB03798/identifier/chebi/

Statements

Subject Item
n2:DB03798
rdf:type
n3:Drug
n3:description
Deoxycytidine (dihydrogen phosphate). A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2'-,3'- or 5- positions. [PubChem]
n3:group
experimental
owl:sameAs
n13:DB03798 n14:DB03798
dcterms:title
2'-Deoxycytidine-5'-Monophosphate
adms:identifier
n6:15918 n7:DB03798 n8:6328614 n9:46506941 n10:C00239 n11:DCM
n3:IUPAC-Name
n4:271B436C-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4372-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4371-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B436E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B436F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4370-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B436A-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4368-363D-11E5-9242-09173F13E4C5 n4:271B436B-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4369-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4378-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4379-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4373-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4374-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4376-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4375-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4377-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
1032-65-1
n3:Bioavailability
n4:271B437E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4380-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4381-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B437D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B437C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B437F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B436D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B437A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B437B-363D-11E5-9242-09173F13E4C5